Researchers at Boston Medical Center’s Grayken Center for Addiction have completed a study that finds that over a 10-year period infective endocarditis (heart valve infection) will cause 20% of those who inject opioids to die. The modeling estimates that 257,800 people are expected to die from infective endocarditis by 2030, which translates to 7,260,000 years of potential life lost. The study was published in Clinical Infectious Diseases
“The expected burden of [infective endocarditis] among people who inject opioids in the U.S. is large,” wrote the researchers, led by Joshua Barocas, M.D., an infectious diseases physician at BMC’s Grayken Center. “Adopting a harm reduction approach, including expansion of syringe service programs, to address injection behaviors could have a major impact on decreasing the mortality associated with the opioid epidemic.”
Last Thursday, Massachusetts Attorney General Maura Healey announced a $1.5 million grant program that aims to promote equity among treatment programs for opioid use disorder in Massachusetts. Promoting Cultural Humility in Opioid Use Disorder Treatment is funded by a settlement that the AG’s Office reached with Injured Workers Pharmacy for unlawful and dangerous prescription drug dispensing practices. The grant program will support recovery programs committed to standards that serve racially, ethnically, and socioeconomically
diverse communities in Massachusetts. Priority will be given to organizations based in the communities they serve.
Applicants can include municipalities, non-profit organizations and quasi-public entities in Massachusetts that will be able to request up to $100,000 over a two-year period to supplement or create opioid use disorder treatment programs that incorporate cultural humility in Massachusetts. Interested applicants can visit here
for more information and for application instructions. Applications must be received by 7 p.m. on October 23, 2020.